BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

428 related articles for article (PubMed ID: 27142781)

  • 1. Comparison of Serum Galactomannan and 1,3-Beta-D-Glucan Determination for Early Detection of Invasive Pulmonary Aspergillosis in Critically Ill Patients with Hematological Malignancies and Septic Shock.
    Lahmer T; Rasch S; Schnappauf C; Beitz A; Schmid RM; Huber W
    Mycopathologia; 2016 Aug; 181(7-8):505-11. PubMed ID: 27142781
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of 1,3-β-d-glucan with galactomannan in serum and bronchoalveolar fluid for the detection of Aspergillus species in immunosuppressed mechanical ventilated critically ill patients.
    Lahmer T; Neuenhahn M; Held J; Rasch S; Schmid RM; Huber W
    J Crit Care; 2016 Dec; 36():259-264. PubMed ID: 27475024
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Usage of 1,3-β-D-Glucan for Early Detection of Invasive Mycoses and Outcome Parameter in Immunocompromised Critically Ill Patients.
    Lahmer T; Held J; Rasch S; Schnappauf C; Beitz A; Schmid RM; Huber W
    Mycopathologia; 2016 Dec; 181(11-12):815-821. PubMed ID: 27619810
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bronchoalveolar lavage fluid and serum 1,3-β-D-glucan testing for invasive pulmonary aspergillosis diagnosis in hematological patients: the role of factors affecting assay performance.
    Weinbergerova B; Kabut T; Kocmanova I; Lengerova M; Pospisil Z; Kral Z; Mayer J
    Sci Rep; 2020 Oct; 10(1):17963. PubMed ID: 33087853
    [TBL] [Abstract][Full Text] [Related]  

  • 5. What should be the optimal cut-off of serum 1,3-β-D-glucan for the detection of invasive pulmonary aspergillosis in patients with haematological malignancies?
    Metan G; Koç AN; Atalay A; Kaynar LG; Ozturk A; Alp E; Eser B
    Scand J Infect Dis; 2012 May; 44(5):330-6. PubMed ID: 22188426
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Performance of serum (1,3)-ß-d-glucan screening for the diagnosis of invasive aspergillosis in neutropenic patients with haematological malignancies.
    Furfaro E; Giacobbe DR; Del Bono V; Signori A; Guolo F; Minetto P; Clavio M; Ballerini F; Gobbi M; Viscoli C; Mikulska M
    Mycoses; 2018 Sep; 61(9):650-655. PubMed ID: 29693758
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of a novel inhalational model of invasive pulmonary aspergillosis in rats and comparative evaluation of three biomarkers for its diagnosis.
    Ahmad S; Al-Shaikh AA; Khan Z
    PLoS One; 2014; 9(6):e100524. PubMed ID: 24955575
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use and limits of (1-3)-β-d-glucan assay (Fungitell), compared to galactomannan determination (Platelia Aspergillus), for diagnosis of invasive aspergillosis.
    Sulahian A; Porcher R; Bergeron A; Touratier S; Raffoux E; Menotti J; Derouin F; Ribaud P
    J Clin Microbiol; 2014 Jul; 52(7):2328-33. PubMed ID: 24740084
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnostic value of serum galactomannan, (1,3)-β-d-glucan, and Aspergillus fumigatus-specific IgA and IgG assays for invasive pulmonary aspergillosis in non-neutropenic patients.
    Dobias R; Jaworska P; Tomaskova H; Kanova M; Lyskova P; Vrba Z; Holub C; Svobodová L; Hamal P; Raska M
    Mycoses; 2018 Aug; 61(8):576-586. PubMed ID: 29575150
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of invasive pulmonary aspergillosis in critically ill patients by combined use of conventional culture, galactomannan, 1-3-beta-D-glucan and Aspergillus specific nested polymerase chain reaction in a prospective pilot study.
    Boch T; Reinwald M; Spiess B; Liebregts T; Schellongowski P; Meybohm P; Rath PM; Steinmann J; Trinkmann F; Britsch S; Michels JD; Jabbour C; Hofmann WK; Buchheidt D
    J Crit Care; 2018 Oct; 47():198-203. PubMed ID: 30015290
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparing the diagnostic value of bronchoalveolar lavage fluid galactomannan, serum galactomannanan, and serum 1,3-β-d-glucan in non-neutropenic respiratory disease patients with invasive pulmonary aspergillosis.
    Dai Z; Cai M; Yao Y; Zhu J; Lin L; Fang L; Li Z; Yi H; Chen B; Liang X
    Medicine (Baltimore); 2021 Apr; 100(14):e25233. PubMed ID: 33832082
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnostic value of the serum galactomannan and (1, 3)-β-D-glucan assays for invasive pulmonary aspergillosis in non-neutropenic patients.
    Cai X; Ni W; Wei C; Cui J
    Intern Med; 2014; 53(21):2433-7. PubMed ID: 25366000
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative accuracy of 1,3 beta-D glucan and galactomannan for diagnosis of invasive fungal infections in pediatric patients: a systematic review with meta-analysis.
    Singh S; Singh M; Verma N; Sharma M; Pradhan P; Chauhan A; Jaiswal N; Chakrabarti A; Singh M
    Med Mycol; 2021 Feb; 59(2):139-148. PubMed ID: 32448907
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Performance of galactomannan, beta-d-glucan, Aspergillus lateral-flow device, conventional culture, and PCR tests with bronchoalveolar lavage fluid for diagnosis of invasive pulmonary aspergillosis.
    Hoenigl M; Prattes J; Spiess B; Wagner J; Prueller F; Raggam RB; Posch V; Duettmann W; Hoenigl K; Wölfler A; Koidl C; Buzina W; Reinwald M; Thornton CR; Krause R; Buchheidt D
    J Clin Microbiol; 2014 Jun; 52(6):2039-45. PubMed ID: 24671798
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A prospective comparison of galactomannan in bronchoalveolar lavage fluid for the diagnosis of pulmonary invasive aspergillosis in medical patients under intensive care: comparison with the diagnostic performance of galactomannan and of (1→ 3)-β-d-glucan chromogenic assay in serum samples.
    Acosta J; Catalan M; del Palacio-Peréz-Medel A; Lora D; Montejo JC; Cuetara MS; Moragues MD; Ponton J; del Palacio A
    Clin Microbiol Infect; 2011 Jul; 17(7):1053-60. PubMed ID: 20825441
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum (1→3)-β-D-glucan and galactomannan levels in patients with cystic fibrosis: a retrospective cohort study.
    Träger J; Melichar VO; Meyer R; Rauh M; Bogdan C; Held J
    BMC Pulm Med; 2018 Mar; 18(1):52. PubMed ID: 29587700
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The role of galactomannan detection in the diagnosis of invasive pulmonary aspergillosis in critically ill patients].
    Shi Y; Liu DW; Long Y; Liu Y; Rui X; Zhou X; Wang XT; DU W
    Zhonghua Nei Ke Za Zhi; 2009 Mar; 48(3):225-30. PubMed ID: 19576092
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Performance of the (1,3)-Beta-D-Glucan Assay on Bronchoalveolar Lavage Fluid for the Diagnosis of Invasive Pulmonary Aspergillosis.
    Linder KA; Kauffman CA; Zhou S; Richards BJ; Kleiboeker S; Miceli MH
    Mycopathologia; 2020 Oct; 185(5):925-929. PubMed ID: 32815095
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Galactomannan testing in bronchoalveolar lavage fluid facilitates the diagnosis of invasive pulmonary aspergillosis in patients with hematologic malignancies and stem cell transplant recipients.
    Nguyen MH; Leather H; Clancy CJ; Cline C; Jantz MA; Kulkarni V; Wheat LJ; Wingard JR
    Biol Blood Marrow Transplant; 2011 Jul; 17(7):1043-50. PubMed ID: 21087680
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Galactomannan testing of bronchoalveolar lavage fluid is useful for diagnosis of invasive pulmonary aspergillosis in hematology patients.
    Hsu LY; Ding Y; Phua J; Koh LP; Chan DS; Khoo KL; Tambyah PA
    BMC Infect Dis; 2010 Mar; 10():44. PubMed ID: 20199673
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.